2010) and recombinant human insulin-like growth factor-1 (rhIGF-1) (Kitamei et al. 2005) have been used to treat DS; the latter was considered to have played a role in the development of diabetes retinopathy (Kitamei et al. 2005). This evidence concerns the gene IGF1 and Dravet syndrome.